1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Youlden DR, Cramb SM, Dunn NA, Muller JM,
Pyke CM and Baade PD: The descriptive epidemiology of female breast
cancer: an international comparison of screening, incidence,
survival and mortality. Cancer Epidemiol. 36:237–248. 2012.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Clark CE, Hingorani SR, Mick R, Combs C,
Tuveson DA and Vonderheide RH: Dynamics of the immune reaction to
pancreatic cancer from inception to invasion. Cancer Res.
67:9518–9527. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Yen TW, Aardal NP, Bronner MP, Thorning
DR, Savard CE, Lee SP and Bell RH Jr: Myofibroblasts are
responsible for the desmoplastic reaction surrounding human
pancreatic carcinomas. Surgery. 131:129–134. 2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Hwang RF, Moore T, Arumugam T,
Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB and Logsdon CD:
Cancer-associated stromal fibroblasts promote pancreatic tumor
progression. Cancer Res. 68:918–926. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Neesse A, Michl P, Frese KK, et al:
Stromal biology and therapy in pancreatic cancer. Gut. 60:861–868.
2011. View Article : Google Scholar
|
7
|
Polyak K and Kalluri R: The role of the
microenvironment in mammary gland development and cancer. Cold
Spring Harb Perspect Biol. 2:a0032442010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bhowmick NA, Neilson EG and Moses HL:
Stromal fibroblasts in cancer initiation and progression. Nature.
432:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gaggioli C, Hooper S, Hidalgo-Carcedo C,
Grosse R, Marshall JF, Harrington K and Sahai E: Fibroblast-led
collective invasion of carcinoma cells with differing roles for
RhoGTPases in leading and following cells. Nat Cell Biol.
9:1392–1400. 2007. View
Article : Google Scholar : PubMed/NCBI
|
11
|
Shimoda M, Mellody KT and Orimo A:
Carcinoma-associated fibroblasts are a rate-limiting determinant
for tumour progression. Semin Cell Dev Biol. 21:19–25. 2010.
View Article : Google Scholar :
|
12
|
Liao D and Johnson RS: Hypoxia: a key
regulator of angiogenesis in cancer. Cancer Metastasis Rev.
26:281–290. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
14
|
Rapisarda A and Melillo G: Role of the
hypoxic tumor microenvironment in the resistance to anti-angiogenic
therapies. Drug Resist Updat. 12:74–80. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lundgren K, Holm C and Landberg G: Hypoxia
and breast cancer: prognostic and therapeutic implications. Cell
Mol Life Sci. 64:3233–3247. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Michieli P: Hypoxia, angiogenesis and
cancer therapy: to breathe or not to breathe. Cell Cycle.
8:3291–3296. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Lei J, Ma J, Ma Q, et al: Hedgehog
signaling regulates hypoxia induced epithelial to mesenchymal
transition and invasion in pancreatic cancer cells via a
ligand-independent manner. Mol Cancer. 12:662013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lei J, Huo X, Duan W, et al: α-Mangostin
inhibits hypoxia-driven ROS-induced PSC activation and pancreatic
cancer cell invasion. Cancer Lett. 347:129–138. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
De Francesco EM, Lappano R, Santolla MF,
Marsico S, Caruso A and Maggiolini M: HIF-1alpha/GPER signaling
mediates the expression of VEGF induced by hypoxia in breast cancer
associated fibroblasts (CAFs). Breast Cancer Res. 15:R642013.
View Article : Google Scholar
|
20
|
Madeo A and Maggiolini M: Nuclear
alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced
gene expression and migration in breast cancer-associated
fibroblasts. Cancer Res. 70:6036–6046. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
22
|
Arias-Pulido H, Chaher N, Gong Y, Qualls
C, Vargas J and Royce M: Tumor stromal vascular endothelial growth
factor A is predictive of poor outcome in inflammatory breast
cancer. BMC Cancer. 12:2982012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Staton CA, Reed MW and Brown NJ: A
critical analysis of current in vitro and in vivo angiogenesis
assays. Int J Exp Pathol. 90:195–221. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Comito G, Giannoni E, Di GP, Segura CP,
Gerlini G and Chiarugi P: Stromal fibroblasts synergize with
hypoxic oxidative stress to enhance melanoma aggressiveness. Cancer
Lett. 324:31–41. 2012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Yu T, Liu M, Luo H, Wu C, Tang X, Tang S,
Hu P, Yan Y, Wang Z and Tu G: GPER mediates enhanced cell viability
and motility via non-genomic signaling induced by 17β-estradiol in
triple-negative breast cancer cells. J Steroid Biochem Mol Biol.
143:392–403. 2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Jiang QF, Wu TT, Yang JY, Dong CR, Wang N,
Liu XH and Liu ZM: 17β-estradiol promotes the invasion and
migration of nuclear estrogen receptor-negative breast cancer cells
through cross-talk between GPER1 and CXCR1. J Steroid Biochem Mol
Biol. 138:314–324. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Dhar A and Ray A: The CCN family proteins
in carcinogenesis. Exp Oncol. 32:2–9. 2010.PubMed/NCBI
|
28
|
Chu CY, Chang CC, Prakash E and Kuo ML:
Connective tissue growth factor (CTGF) and cancer progression. J
Biomed Sci. 15:675–685. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Hall-Glenn F, De Young RA, Huang BL, et
al: CCN2/connective tissue growth factor is essential for pericyte
adhesion and endothelial basement membrane formation during
angiogenesis. PLoS One. 7:e305622012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Ronnov-Jessen L and Petersen OW: Induction
of alpha-smooth muscle actin by transforming growth factor-beta 1
in quiescent human breast gland fibroblasts. Implications for
myofibroblast generation in breast neoplasia. Lab Invest.
68:696–707. 1993.PubMed/NCBI
|
32
|
Ellis MJ, Singer C, Hornby A, Rasmussen A
and Cullen KJ: Insulin-like growth factor mediated
stromal-epithelial interactions in human breast cancer. Breast
Cancer Res Treat. 31:249–261. 1994. View Article : Google Scholar : PubMed/NCBI
|
33
|
Bronzert DA, Pantazis P, Antoniades HN,
Kasid A, Davidson N, Dickson RB and Lippman ME: Synthesis and
secretion of platelet-derived growth factor by human breast cancer
cell lines. Proc Natl Acad Sci USA. 84:5763–5767. 1987. View Article : Google Scholar : PubMed/NCBI
|
34
|
Taddei ML, Giannoni E, Raugei G, Scacco S,
Sardanelli AM, Papa S and Chiarugi P: Mitochondrial oxidative
stress due to complex I dysfunction promotes fibroblast activation
and melanoma cell invasiveness. J Signal Transduct.
2012:6845922012. View Article : Google Scholar : PubMed/NCBI
|
35
|
Giannoni E, Bianchini F, Masieri L, Serni
S, Torre E, Calorini L and Chiarugi P: Reciprocal activation of
prostate cancer cells and cancer-associated fibroblasts stimulates
epithelial-mesenchymal transition and cancer stemness. Cancer Res.
70:6945–6956. 2010. View Article : Google Scholar : PubMed/NCBI
|
36
|
Cirri P and Chiarugi P:
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison
driving cancer progression. Cancer Metastasis Rev. 31:195–208.
2012. View Article : Google Scholar
|
37
|
Giannoni E, Bianchini F, Calorini L and
Chiarugi P: Cancer associated fibroblasts exploit reactive oxygen
species through a proinflammatory signature leading to epithelial
mesenchymal transition and stemness. Antioxid Redox Signal.
14:2361–2371. 2011. View Article : Google Scholar : PubMed/NCBI
|
38
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
39
|
Giaccia AJ and Schipani E: Role of
carcinoma-associated fibroblasts and hypoxia in tumor progression.
Curr Top Microbiol Immunol. 345:31–45. 2010.PubMed/NCBI
|
40
|
Melillo G: Targeting hypoxia cell
signaling for cancer therapy. Cancer Metastasis Rev. 26:341–352.
2007. View Article : Google Scholar : PubMed/NCBI
|
41
|
Recchia AG, De Francesco EM, Vivacqua A,
Sisci D, Panno ML, Ando S and Maggiolini M: The G protein-coupled
receptor 30 is up-regulated by hypoxia-inducible factor-1alpha
(HIF-1alpha) in breast cancer cells and cardiomyocytes. J Biol
Chem. 286:10773–10782. 2011. View Article : Google Scholar : PubMed/NCBI
|
42
|
Lappano R, Recchia AG, De Francesco EM,
Angelone T, Cerra MC, Picard D and Maggiolini M: The cholesterol
metabolite 25-hydroxycholesterol activates estrogen receptor
alpha-mediated signaling in cancer cells and in cardiomyocytes.
PLoS One. 6:e166312011. View Article : Google Scholar
|
43
|
Pandey DP, Lappano R, Albanito L, Madeo A,
Maggiolini M and Picard D: Estrogenic GPR30 signalling induces
proliferation and migration of breast cancer cells through CTGF.
EMBO J. 28:523–532. 2009. View Article : Google Scholar : PubMed/NCBI
|
44
|
Semenza GL: Oxygen homeostasis. Wiley
Interdiscip Rev Syst Biol Med. 2:336–361. 2010. View Article : Google Scholar : PubMed/NCBI
|
45
|
Youn SW, Lee SW, Lee J, et al: COMP-Ang1
stimulates HIF-1α-mediated SDF-1 overexpression and recovers
ischemic injury through BM-derived progenitor cell recruitment.
Blood. 117:4376–4386. 2011. View Article : Google Scholar : PubMed/NCBI
|